Intracerebroventricular injection of interleukin-1 stimulates the release of high levels of interleukin-6 and interleukin-1 receptor antagonist into peripheral blood in the primate

被引:24
|
作者
Xiao, EN
Xia, LN
Ferin, M
Wardlaw, SL
机构
[1] Columbia Univ Coll Phys & Surg, Dept Med, New York, NY 10032 USA
[2] Columbia Univ Coll Phys & Surg, Dept Obstet & Gynecol, New York, NY 10032 USA
关键词
interleukin-1; interleukin-6; interleukin-1 receptor antagonist; ACTH; hypothalamic-pituitary-adrenal axis;
D O I
10.1016/S0165-5728(99)00050-8
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Previous studies in the rodent have shown that the cytokine IL-1 can act within the brain to influence peripheral IL-6 secretion. In order to determine if such an interaction occurs in the primate, we have compared the effects of intracerebroventricular vs. intravenous injection of IL-1 beta on the release of IL-6 into the peripheral circulation of the monkey. The effects of i.c.v. IL-1 beta on the release of the IL-1 receptor antagonist (IL-1ra) were studied in parallel. For comparison, we have also measured the release of both IL-6 and IL-1ra into lumbar CSF after i.c.v. IL-1 beta injection. Ten ovariectomized rhesus monkeys with indwelling lateral ventricular and peripheral venous cannulae were studied. Human rIL-1 beta (400 ng) was infused either i.c.v. or i.v. over 30 min and blood samples were collected for IL-6 and IL-1ra measurement by monoclonal human ELISAs. Although both i.c.v. and i.v. IL-1 beta stimulated IL-6 and IL-1ra release into peripheral blood, the stimulation was much more profound after i.c.v, injection (p < 0.001). Peak IL-6 levels were 2010 +/- 590 pg/ml after i.c.v. IL-1 beta compared to 243 +/- 60 pg/ml after i.v. IL-1 beta. Peak IL-1ra levels were 61,310 +/- 16,190 pg/ml after i.c.v. IL-1 beta compared to 18,175 +/- 4270 pg/ml after i.v. IL-1 beta. There was no significant effect of an i.c.v. saline infusion on peripheral IL-6 or IL-1ra levels. In four animals, lumbar CSF was collected 7 h after i.c.v, IL-1 beta injection. The mean concentration of IL-6 in CSF was 103, 570 +/- 13,780 pg/ml after i.c.v. IL-1 beta vs. 224 +/- 190 pg/ml after i.c.v. saline injection; IL-1ra was 47,460 +/- 6290 pg/ml vs. 1040 +/- 550 pg/ml, As expected, both i.c.v. and i.v. IL-beta stimulated ACTH and cortisol release, the stimulation was significantly greater after i.c.v. compared to i.v. administration(p < 0.001). Thus, in the monkey, i.c.v. injection of IL-1 beta stimulates the release of large amounts of IL-6 and IL-1ra into the CSF and the peripheral circulation. Both IL-6 and IL-1ra were released into the peripheral circulation to a much greater extent after i.c.v. compared to i.v. IL-1 beta infusion. These studies provide further support in the primate for a mechanism by which inflammation within the brain could induce a variety of systemic responses. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:70 / 76
页数:7
相关论文
共 50 条
  • [41] Inhibition of Interleukin-6 Signaling on Aortitis in Interleukin-1 Receptor Antagonist Deficient Mice
    Hada, Yoshiko
    Uchida, Haruhito A.
    Mukai, Tomoyuki
    Kojima, Fumiaki
    Otaka, Nozomu
    Onishi, Yasuhiro
    Morita, Yoshitaka
    Iwakura, Yoichiro
    Wada, Jun
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2019, 39
  • [42] Transcriptional regulation of oxytocin receptor by interleukin-1β and interleukin-6
    Schmid, B
    Wong, S
    Mitchell, BF
    ENDOCRINOLOGY, 2001, 142 (04) : 1380 - 1385
  • [43] Interleukin-1β and interleukin-1 receptor antagonist levels in cerebrospinal fluid of aseptic meningitis patients
    Yokoyama, T
    Oda, M
    Seino, Y
    PEDIATRIC ALLERGY AND IMMUNOLOGY, 1998, 9 (02) : 91 - 96
  • [44] DISCRIMINATION BETWEEN INTERLEUKIN-1 AND INTERLEUKIN-6
    HELLE, M
    BOEIJE, L
    AARDEN, LA
    LYMPHOKINE RESEARCH, 1988, 7 (03): : 329 - 329
  • [45] Influence of dialysis membranes on interleukin-1 beta and interleukin-1 receptor antagonist production by peripheral blood mononuclear cells
    Higuchi, T
    Kuno, T
    Takahashi, S
    Kanmatsuse, K
    ARTIFICIAL ORGANS, 1997, 21 (04) : 265 - 271
  • [46] Haplotypes of the interleukin-1 receptor antagonist gene, interleukin-1 receptor antagonist mRNA levels and the risk of myocardial infarction
    van Minkelen, Rick
    Wettinger, Stephanie Bezzina
    de Visser, Marieke C. H.
    Vos, Hans L.
    Reitsma, Pieter H.
    Rosendaal, Frits R.
    Bertina, Rogier M.
    Doggen, Carine J. M.
    ATHEROSCLEROSIS, 2009, 203 (01) : 201 - 205
  • [47] Cellulose acetate beads induce release of interleukin-1 receptor antagonist, but not tumour necrosis factor-α or interleukin-1β in human peripheral blood
    Takeda, Y
    Hiraishi, K
    Takeda, H
    Shiobara, N
    Shibusawa, H
    Saniabadi, AR
    Adachi, M
    Kawata, S
    INFLAMMATION RESEARCH, 2003, 52 (07) : 287 - 290
  • [48] Cellulose acetate beads induce release of interleukin-1 receptor antagonist, but not tumour necrosis factor-α or interleukin-1β in human peripheral blood
    Y. Takeda
    K. Hiraishi
    H. Takeda
    N. Shiobara
    H. Shibusawa
    A. R. Saniabadi
    M. Adachi
    S. Kawata
    Inflammation Research, 2003, 52 : 287 - 290
  • [49] Interleukin-1β, Interleukin-1 Receptor Antagonist, and Soluble Interleukin-1 Receptor Type II Secretion in Chronic Fatigue Syndrome
    Joseph G. Cannon
    Jonathan B. Angel
    Leslie W. Abad
    Edouard Vannier
    Maria D. Mileno
    Laura Fagioli
    Sheldon M. Wolff
    Anthony L. Komaroff
    Journal of Clinical Immunology, 1997, 17 : 253 - 261
  • [50] Localisation of mRNA for interleukin-1 receptor and interleukin-1 receptor antagonist in the rat ovary
    Wang, LJ
    Brannstrom, M
    Cui, KH
    Simula, AP
    Hart, RP
    Maddocks, S
    Norman, RJ
    JOURNAL OF ENDOCRINOLOGY, 1997, 152 (01) : 11 - 17